feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / AI Slashes Interval Cancers: A Screening Breakthrough

AI Slashes Interval Cancers: A Screening Breakthrough

6 Feb

•

Summary

  • AI reduced aggressive interval breast cancers by 12% in a large Swedish trial.
  • AI supported radiologists, significantly cutting their workload.
  • The AI tool flagged suspicious areas, aiding radiologist interpretation.
AI Slashes Interval Cancers: A Screening Breakthrough

A Swedish breast screening trial involving nearly 100,000 women has demonstrated the potential of artificial intelligence to enhance cancer detection and reduce radiologist workload. The study, conducted between April 2021 and December 2022, randomly assigned women aged 40 to 80 to either standard screening with two radiologists or an AI-supported approach. In the AI-supported group, AI flagged suspicious areas on mammograms, leading to an 11-fewer interval cancer diagnosis—a 12 percent reduction compared to standard screening. Researchers noted that interval cancers, diagnosed between routine screenings, tend to be more aggressive and harder to treat. The AI system acts as a support tool, aiding radiologists in interpretation rather than replacing them. Furthermore, the AI-assisted method reduced radiologist workload by 44 percent, a significant benefit for institutions experiencing staff shortages. While AI-assisted mammography is being implemented in parts of Sweden and Denmark, experts emphasize that it is not yet ready to replace human oversight and requires rigorous testing.

trending

Bitcoin price struggles amid fragility

trending

Buddha relics travel from Vadodara

trending

Mrunal Thakur wedding rumours

trending

Suzlon Energy Q3 results up

trending

Savannah Guthrie pleads for mother

trending

Australia vs Netherlands warm-up

trending

RCB wins WPL match

trending

Bas de Leede admires Pandya

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
AI helped detect fewer fast-growing, hard-to-treat interval breast cancers, showing a 12 percent reduction in the AI-supported group.
No, the AI acted as a support tool, highlighting suspicious areas for radiologists who made the final recall decision.
Reducing interval cancers is important because they are known to be more aggressive and lead to poorer patient outcomes.

Read more news on

Healthside-arrowDenmarkside-arrowSwedenside-arrowArtificial Intelligence (AI)side-arrow

You may also like

AI Boom Fuels Record Orders for ASML

28 Jan • 66 reads

article image

Europe's AI Race: Building Independence

19 Jan • 129 reads

article image

Steam Power's Legacy: Early Tech Boosts German Wages

14 Jan • 61 reads

article image

AI Therapy: African languages tackle mental health

5 Jan • 223 reads

article image

World Richer Than Ever, Yet Deeply Out of Balance

2 Jan • 291 reads

article image